An ANOCEF Genomic and Transcriptomic Microarray Study of the Response to Irinotecan and Bevacizumab in Recurrent Glioblastomas

Background. We performed a retrospective study to assess whether the initial molecular characteristics of glioblastomas (GBMs) were associated with the response to the bevacizumab/irinotecan chemotherapy regimen given at recurrence. Results. Comparison of the genomic and gene expression profiles of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Laffaire, Julien, Stefano, Anna Luisa Di, Chinot, Olivier, Idbaih, Ahmed, Gallego Perez-Larraya, Jaime, Marie, Yannick, Vintonenko, Nadia, Boisselier, Blandine, Farina, Patrizia, Delattre, Jean-Yves, Figarella-Branger, Dominique, Honnorat, Jérôme, Sanson, Marc, Ducray, François
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3996912/
https://ncbi.nlm.nih.gov/pubmed/24804210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/282815
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares